Paciente con betatalasemia mayor y 2 embarazos a término

Beneitez, David; Casellas, Manel; Alícia Carrera, Alicia; Duran-Suárez, Joan Ramón.
Med. clín (Ed. impr.) ; 130(6): 238-238, feb. 2008.
Artículo en Es | IBECS (España) | ID: ibc-63521

Documentos relacionados

  1. Splenic iron decreases without change in volume or liver parameters during luspatercept therapy.
  2. Lactate administration improves laboratory parameters in murine models of iron overload.
  3. Health-related quality of life in patients with ß-thalassemia: Data from the phase 3 BELIEVE trial of luspatercept.
  4. Hyperhaemolytic transfusion reaction in two ß-thalassaemia major patients: The role of eculizumab.
  5. Psychological intervention in children with transfusion-dependent ß-thalassaemia.
  6. How I treat non-transfusion-dependent ß-thalassemia.
  7. Luspatercept, a two-edged sword in beta-thalassemia-associated paravertebral extramedullary hematopoietic masses (EHMs).
  8. Management of luspatercept therapy in patients with transfusion-dependent ß-thalassaemia.
  9. A Pragmatic Scoring Tool to Predict Hydroxyurea Response Among ß-Thalassemia Major Patients in Pakistan.
  10. The potential hepatoprotective effect of metformin in hepatitis C virus-infected adolescent patients with beta thalassemia major: Randomised clinical trial.